CryoLife (CRY) Reports In-Line Q1 EPS; Retains Outlook

CryoLife (NYSE: CRY) reported Q1 EPS of $0.04, in-line with the analyst estimate of $0.04. Revenue for the quarter came in at $67.5 million versus the consensus estimate of $66.36 million.

GUIDANCE:

CryoLife is reiterating its full-year financial guidance, with total revenues for 2019 expected to be in the range of $280 million to $284 million and non-GAAP earnings per share expected to be between $0.28 and $0.32.

For earnings history and earnings-related data on CryoLife (CRY) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c